ATI Physical Therapy Revenue 2020-2024 | ATIP

ATI Physical Therapy revenue from 2020 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
ATI Physical Therapy Annual Revenue
(Millions of US $)
2023 $699
2022 $636
2021 $628
2020 $592
2019 $785
ATI Physical Therapy Quarterly Revenue
(Millions of US $)
2024-03-31 $181
2023-12-31 $182
2023-09-30 $177
2023-06-30 $172
2023-03-31 $167
2022-12-31 $162
2022-09-30 $157
2022-06-30 $163
2022-03-31 $154
2021-12-31 $156
2021-09-30 $159
2021-06-30 $164
2021-03-31 $149
2020-12-31
2020-09-30 $149
2020-06-30 $108
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.026B $0.699B
ATI Physical Therapy Inc. is a portfolio company of Advent International as well as provider of outpatient physical therapy services. ATI Physical Therapy Inc., formerly known as Fortress Value Acquisition Corp. II, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00